CARDIOVASCULAR JOURNAL OF AFRICA • Vol 24, No 7, August 2013
AFRICA
269
14. Elias AN, Eng S. Homocysteine concentrations in patients with diabetes
mellitus – relationship to microvascular and macrovascular disease.
Diabetes Obesity Metab
2005; 117–121.
15. Vayá A, Carmona P, Badia N, Pérez R, Hernandez MA, Corella D.
Homocysteine levels and the metabolic syndrome in a Mediterranean
population.
Clin Hemorheol Microcirc
2011;
47
(1): 59–66.
16. Wedro BC. 2009 Blood pressure guidelines. Available at
.
medicinenet.com/script/main/art.asp?articlekey=83068. [Accessed:
21/09/2011].
17. Lim K, Steinberg G. Preeclampsia. 2010. Available from:
-
cine.medscape.com/article/1476919-overview. [Accessed: 20/9/2011].
18. Sen U, Tyagi SC. Homocysteine and hypertension in diabetes: Does
PPAR
γ
have a regulatory role?
PPAR Res
2010, Article ID 806538,
doi:10.1155/2010/806538.
19. Atif A, Rizvi MA, Tauheed S, Aamir I, Majeed F, Siddiqui K,
et al.
Serum homocysteine concentrations in patients with hypertension.
Pak
J Physiol
2008;
4
(1):
21–22.
20. Nabipour I, Ebrahim A, Jafari SM, Vahdat K, Assadi M, Movahed A,
et al
. The metabolic syndrome is not associated with homocysteinemia:
The Persian Gulf healthy heart study.
J Endocrinol Invest
2009;
32
(5):
406–410.
21. Sundström J, Sullivan L, D’Agostino RB, Jacques PF, Selhub J,
Rosenberg IH,
et al.
Plasma homocysteine, hypertension incidence, and
blood pressure tracking. The Framingham heart study.
Hypertension
2003;
42
: 1100–1105.
22. Stehouwer CD, van Guldener C. Does homocysteine cause hyperten-
sion?
Clin Chem Lab Med
2003;
41
(11): 1408–1411.
23. Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV,
Stein JH,
et al.
Lipoprotein management in patients with cardio-meta-
bolic risk.
J Am Coll of Cardiol
2008;
31
(4): 811–822
.
24. Mahan LK, Escort-Stump S.
Food, Nutrition and Diet Therapy
, 11th
edn. Philadelphia: Elsevier 2007: 41, 46.
25. Mahan LK, Escort-Stump S.
Food, Nutrition and Diet Therapy
, 11th
edn. Philadelphia: Elsevier 2007: 864, 866, 872.
26. Nelson DL, Cox MM.
Digestion, Mobilization, and Transport of Fats
,
5th edn, NewYork: WH Freeman and Co 2008: 346–347.
27. Barter P, Gotto AM, Larosa JC, Maroni J, Szarek M. HDL cholesterol,
very low levels of LDL cholesterol and cardiovascular events.
N Engl J
Med
2007;
357
(13): 1301–1310.
28. Cziraky MJ, Watson KE, Talbert RL. Targeting low HDL-cholesterol to
decrease residual cardiovascular risk in managed care setting.
J Manag
Care Pharm
2008;
14
(8): S3–S28.
29. Fahy E, Subramaniam S, Brown HA. A comprehensive classification
system for lipids.
J Lipid Res
2005;
46
(5): 839–862.
30. Obeid R, Herrmann W. Homocysteine and cholesterol: Guilt by asso-
ciation
?
Stroke
2009;
40
(7): e516.
31. Rippey FF.
Thrombosis and Embolism. General Pathology
, 1st edn,
Johannesburg: Witwatersrand University Press 2003: 103–109.
32. Malhotra R, Hoyo C, Ostbye T, Hughes G, Schwartz D, Tsolekile L,
et
al
. Deteminants of obesity in an urban township of South Africa.
S Afr
J Clin Nutr
2008;
21
(4): 315–320.
33. Darvall KA, Sam RC, Silverman SH, Bradbury AW, Adam DJ. Obesity
and thrombosis.
Eur J Vasc Endovasc Surg
2007;
33
: 223–233.
34. Bodary PF, Randal J, Westrick BS, Wickenheiser KJ, Shen Y, Daniel T,
et al.
Effect of leptin on arterial thrombosis following vascular injury in
mice.
J Am Med Ass
2002;
287
(13): 1706–1709.
35. Goedecke JH, Jennings CL, Lambert EV. Obesity in South Africa.
Chronic diseases of lifestyle in South Africa since 1995–2005. Cape
Town: South African Medical Research Council, 2006: 65–79.
36. Sanlier N, Yabanci N. 2007. Relationship between body mass index,
lipids and homocysteine levels in university students
. J Pak Med Assoc
2007;
57
(10): 491–495.
37. EL Sammak M, Kandil M, EL-Hifni S, Hosni R, Ragab M. Elevated
plasma homocysteine is positively associated with age independent of
C677T mutation of the methylenetetrahydrofolate reductase gene in
selected Egyptian subjects.
Int J Med Sci
2004;
1
: 181–192.
